Calico Life Sciences LLC

8 clinical trials · Sponsor

Record	Firm	Date
ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD) (NCT06902558)	Calico Life Sciences LLC	2025-06-09
Study of [14C] ABBV-CLS-7262 in Healthy Male Volunteers Following Single Oral Dose Administration (NCT06425003)	Calico Life Sciences LLC	2024-05-21
A Thorough QT Study of ABBV-CLS-7262 in Healthy Subjects (NCT06310876)	Calico Life Sciences LLC	2024-03-14
A Phase 1 Study Assessing the Effect of Food on the Pharmacokinetics of ABBV- CLS-7262 (NCT06145607)	Calico Life Sciences LLC	2023-12-19
A Phase 1 Study of ABBV-CLS-7262, Rosuvastatin, and Digoxin in Healthy Subjects (NCT05763459)	Calico Life Sciences LLC	2023-03-24
An Open-Label Exploratory Study of Fosigotifator in Participants With Vanishing White Matter Disease (NCT05757141)	Calico Life Sciences LLC	2023-03-13
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors (NCT04777994)	Calico Life Sciences LLC	2021-03-09

Every clearance here is in the API, with alerts when new ones post.